CD209 and rectum adenocarcinoma: We found that the reduced CD209 expression was associated with a poor overall survival rate in LUAD (p = 0.012, HR = 0.69), READ (rectum adenocarcinoma) (p = 0.052, HR = 0.46), and (cervical squamous cell carcinoma) (p = 0.034, HR = 0.52).